Validity and reliability of the revised convergence insufficiency symptom survey in adults.
Michael W Rouse, Eric J Borsting, G Lynn Mitchell...
https://pubmed.ncbi.nlm.nih.gov/15315652/Actively Recruiting
Led by Jordi Zaragoza · Updated on 2026-10-13
100
Participants Needed
1
Research Sites
N/A
Total Duration
Vergence disorders are common binocular vision problems causing symptoms like eyestrain, blurred vision, headaches, and difficulty focusing during close-up activities, especially with prolonged use of digital devices. Optometric vision therapy is the standard treatment but does not work equally well for everyone. This study evaluates whether adding osteopathic manual therapy to vision therapy offers extra benefits compared with vision therapy alone or combined with a sham osteopathic procedure in adults with these disorders. Participants are randomly assigned to one of three groups vision therapy alone vision therapy plus osteopathic manual therapy or vision therapy plus a sham osteopathic intervention. Vision therapy includes structured in-office and home exercises targeting eye coordination. The osteopathic treatment involves two manual therapy sessions spaced about three weeks apart, while the sham treatment mimics these sessions without therapeutic techniques. Vision therapy sessions occur 1-2 times per week, for a total of 8 sessions. Participants undergo evaluations before treatment, within two weeks after finishing vision therapy, and at 3 and 6 months post-treatment. These assessments measure eye movement performance using video-oculography devices and symptom severity through a validated questionnaire. The study also explores how physical dysfunctions relate to visual symptoms. Outcomes include changes in eye movement reaction time, precision, and symptom scores. The study aims to improve understanding of osteopathys role alongside vision therapy in managing vergence disorders.
CONDITIONS
Effectiveness of Osteopathy as an Adjunct to Optometric Vision Therapy in Vergence Disorders
J
JORDI Z ZARAGOZA BORT, MSc
J
JORDI Z ZARAGOZA BORT, DO
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Jordi Zaragoza
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 6 to 8 weeks
Participants receive vision therapy alone or combined with osteopathic manual therapy or a sham osteopathic intervention. Vision therapy includes structured in-office and home exercises. Osteopathic or sham treatments include two sessions spaced about three weeks apart. Vision therapy sessions are delivered 1-2 times per week for a total of 8 sessions.
1 to 2 sessions per week for vision therapy; 2 osteopathic or sham sessions
Duration - 6 months
Participants are evaluated on eye movement performance and symptoms using video-oculography and questionnaires at post-treatment, and again at 3 and 6 months after treatment completion.
3 follow-up assessments
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Michael W Rouse, Eric J Borsting, G Lynn Mitchell...
https://pubmed.ncbi.nlm.nih.gov/15315652/S J Challacombe, C Scully, B Keevil...
https://pubmed.ncbi.nlm.nih.gov/6411882/Elizabeth A Rankin, Mary B Delashmutt
https://pubmed.ncbi.nlm.nih.gov/17098882/Debbie Walker
https://pubmed.ncbi.nlm.nih.gov/20683468/Britta Brügger
https://pubmed.ncbi.nlm.nih.gov/24606142/D Pringuey, E Fakra, F Cherikh...
https://pubmed.ncbi.nlm.nih.gov/23279985/Ronald P DeMatteo, Robert G Maki, Samuel Singer...
https://pubmed.ncbi.nlm.nih.gov/17435539/Convergence Insufficiency Treatment Trial Study Group
https://pubmed.ncbi.nlm.nih.gov/18852411/Jordi Zaragoza
Lead Sponsor